Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Gibson Christopher Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 59,794 shares @ $7.2085, valued at $431k
Exercised 31,250 options to buy @ $2.48, valued at $77.5k
10/04/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 16,913 shares @ $9.19, valued at $155.4k
08/11/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Converted 10,000 shares @ $0
Gifted 10,000 shares @ $0
Converted 10,000 options to buy @ $0
08/04/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 60,955 shares @ $13.0171, valued at $793.5k
Sold 4,060 shares @ $13.3631, valued at $54.3k
Exercised 8,674 options to buy @ $11.4, valued at $98.9k
Exercised 31,250 options to buy @ $2.48, valued at $77.5k
08/02/2023 144 Form 144 - Report of proposed sale of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/12/2023 144 Form 144 - Report of proposed sale of securities:
07/12/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Converted 10,000 shares @ $0
Gifted 10,000 shares @ $0
Converted 10,000 options to buy @ $0
06/09/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 56,436 shares @ $9.0511, valued at $510.8k
Exercised 31,250 options to buy @ $2.48, valued at $77.5k
06/07/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 11,661 shares @ $5.6, valued at $65.3k
05/05/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Converted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Converted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Converted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Gifted 8,662 shares @ $0
Converted 1,338 shares @ $0
Gifted 1,338 shares @ $0
Sold 33,073 shares @ $4.7096, valued at $155.8k
Converted 4,000 shares @ $0
05/03/2023 144 Form 144 - Report of proposed sale of securities:
05/03/2023 144 Form 144 - Report of proposed sale of securities:
04/28/2023 4/A Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Converted 3,000 options to buy @ $0
Converted 18,500 options to buy @ $0
Converted 12,000 shares @ $0
Gifted 12,000 shares @ $0
Converted 12,000 shares @ $0
Gifted 12,000 shares @ $0
Converted 12,000 shares @ $0
Gifted 12,000 shares @ $0
Converted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Converted 3,000 shares @ $0
04/06/2023 144 Form 144 - Report of proposed sale of securities:
04/05/2023 144 Form 144 - Report of proposed sale of securities:
03/15/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Converted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Converted 3,000 options to buy @ $0
03/10/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 70,890 shares @ $8.096, valued at $573.9k
Gifted 10,000 shares @ $0
Converted 4,000 shares @ $0
Sold 4,000 shares @ $8.0904, valued at $32.4k
Converted 20,000 shares @ $0
Sold 20,000 shares @ $8.095, valued at $161.9k
Converted 1,000 shares @ $0
Sold 1,000 shares @ $8.0867, valued at $8.1k
Sold 15,000 shares @ $7.7747, valued at $116.6k
Exercised 93,750 options to buy @ $2.48, valued at $232.5k
Converted 4,000 options to buy @ $0
03/06/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Converted 18,500 shares @ $0
Sold 18,500 shares @ $7.919, valued at $146.5k
Converted 500 shares @ $0
Sold 500 shares @ $7.9041, valued at $4k
Converted 1,000 shares @ $0
Sold 1,000 shares @ $7.9059, valued at $7.9k
Converted 1,000 shares @ $0
Sold 1,000 shares @ $7.9086, valued at $7.9k
Converted 18,500 options to buy @ $0
Converted 500 options to buy @ $0
Converted 1,000 options to buy @ $0
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Gifted 12,000 shares @ $0
Gifted 12,000 shares @ $0
Gifted 12,000 shares @ $0
Gifted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Gifted 3,000 shares @ $0
Converted 18,500 shares @ $0
12/02/2022 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 18,710 shares @ $8.7731, valued at $164.1k
Converted 18,500 shares @ $0
Sold 18,500 shares @ $9.2765, valued at $171.6k
Converted 500 shares @ $0
Sold 500 shares @ $9.2648, valued at $4.6k
Converted 1,000 shares @ $0
Sold 1,000 shares @ $9.2773, valued at $9.3k
Converted 1,000 shares @ $0
Sold 1,000 shares @ $9.2773, valued at $9.3k
Converted 18,500 options to buy @ $0
Exercised 31,250 options to buy @ $2.48, valued at $77.5k
11/17/2022 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 5,751 shares @ $11.86, valued at $68.2k
11/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2022 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 17,553 shares @ $11.5033, valued at $201.9k
Converted 18,500 shares @ $0
Sold 18,500 shares @ $11.6514, valued at $215.6k
Converted 500 shares @ $0
Sold 500 shares @ $11.6421, valued at $5.8k
Converted 1,000 shares @ $0
Sold 1,000 shares @ $11.6428, valued at $11.6k
Converted 1,000 shares @ $0
Sold 1,000 shares @ $11.6414, valued at $11.6k
Converted 18,500 options to buy @ $0
Exercised 31,250 options to buy @ $2.48, valued at $77.5k
09/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy